Pneumonia during remission induction chemotherapy in patients with AML or MDS

Leukemia

Volumn 10, Issue 12, 1996, Pages 1870-1873

  Wilhelm, M ^a   Kantarjian, H M ^b   O'Brien, S ^b   Pierce, S ^b   Keating, M J ^c   Freireich, E J ^b   Estey, E H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MD Anderson Cancer Center ^*

Author keywords

Acute myeloid leukemia; Amphotericin B; Induction therapy; Myelodysplastic syndrome; Pneumonia

Indexed keywords

AMPHOTERICIN B; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMIDAZOLE; RETINOIC ACID; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; FUNGUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; LEUKOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030451395     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Maschmeyer C, Link H, Hiddemann W, Meyer P. Helmerking M, Eisenmann E, Schmitt J, Adam D. Pulmonary infiltrations in febrile patients with neutropenia. Cancer 1994; 73: 2296-2304.
2. Bodey GP. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993; 17 (Suppl. 2): S378-384.
3. Peters SC, Meadows JA, Gracey DR. Outcome of respiratory failure in hematologic malignancy. Chest 1988; 94: 99-102.
4. Novakova IR, Donnelly JP, De Pauw B. Potential sites of infection that develop in febrile neutropenic patients. Leuk Lymphoma 1993; 10:461-467.
5. Chanock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993; 7: 771-793.
6. Walsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin infect Dis 1994; 18: 793-798.
7. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ. Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982; 60: 309-315.
8. Anderlini P, Luna M, Kantarjian HM, O'Brien S, Pierce S, Keating MJ, Estey EH. Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromes. Leukemia 1996; 10: 600-608.
9. Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Hematol Pathol 1987; 1: 203-208.
10. Estey EH. Prognosis and therapy of myelodysplastic syndromes. Cancer Treat Res 1993; 64: 233-267.
11. Sainz CF, Sainz MA. Prognostic factors in myelodysplastic syndromes. Leuk Res 1992; 16: 77-86.
12. Estey E, Smith TL, Keating MJ, McCredie KB, Gehan EA, Freireich EJ. Prediction of survival during induction therapy in patients with newly-diagnosed acute myeloblastic leukemia. Leukemia 1989; 3: 257-263.
13. Bodey GP. Infection in cancer patients. A continuing association. (Review). Am J Med 1986; 81: 11-26.
14. Bodey GP. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986; 80: 112-119.
15. Commers JR, Robichaud KJ, Pizzo PA. New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics. Pediatr Meet Dis 1984; 3: 423-428.
16. Holleran WM, Wllbur JR, DeGregorio MW. Empiric amphotericin B therapy in patients with acute leukemia. Rev Infect Dis 1985; 7: 619-624.
17. EORTC. International Antimicrobial Therapy Cooperative Group. Empirical antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-672.
18. Stein RS, Kayser J, Flexner JM. Clinical value of empirical amphotericin B in patients with acute myelogenous leukemia. Cancer 1982; 50: 2247-2251.
19. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Willimas B, Storb R, Thomas ED, Buckner CD. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
20. Casper CP, Seger RA, Burger J, Gmür J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993; 81: 2866-2871.
21. Jendiroba DB, Lichtiger B, Hester JP, O'Brien S, Kantarjian H, Reddy V, Freireich EJ, Anaissie E. Evaluation and comparison of three mobilization methods for granulocyte collection. Blood 1995; 10 (Suppl. 1): 609a.